Drugs / Sabin Inactivated Poliovirus Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT05460377 Comparator | Jul 2022 → Jul 2023 | poliomyelitis | Centers for Disease Control and Prevention | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sabin Inactivated Poliovirus Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05460377 ↗ |
| Known as | sIPV | “several manufacturers establishing production of IPV using Sabin strains (sIPV)” NCT05460377 ↗ |
| Modality | Vaccine | “Sabin IPV intramuscularly” NCT05460377 ↗ |
| Route | Intramuscular | “will be delivered intramuscularly by needle and syringe” NCT05460377 ↗ |